Filing Details
- Accession Number:
- 0000898432-20-000119
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-02-20 16:06:39
- Reporting Period:
- 2020-02-18
- Accepted Time:
- 2020-02-20 16:06:39
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1325618 | Iradimed Corp | IRMD | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1254747 | Brent Johnson | C/O Iradimed Corporation 1025 Willa Springs Dr. Winter Springs FL 32708 | Exec. Vp. Of Ww Sales And Mktg | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-02-18 | 12,106 | $0.93 | 15,046 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-02-18 | 12,106 | $26.00 | 2,940 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2020-02-19 | 7,453 | $0.93 | 10,393 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-02-19 | 7,453 | $26.00 | 2,940 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-02-18 | 12,106 | $0.00 | 12,106 | $0.93 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-02-19 | 7,453 | $0.00 | 7,453 | $0.93 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 57,362 | 2022-11-01 | No | 4 | M | Direct | |
| 49,909 | 2022-11-01 | No | 4 | M | Direct |
Footnotes
- The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.
- This transaction was executed in multiple trades at prices ranging from $25.81 to $26.56. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $26.00 to $26.11. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This option, representing a right to purchase a total of 278,408 shares, was granted on November 1, 2012 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date.
Billionaire Hedge Funds
